» Articles » PMID: 20347873

Optimal Promoter Usage for Lentiviral Vector-mediated Transduction of Cultured Central Nervous System Cells

Overview
Specialty Neurology
Date 2010 Mar 30
PMID 20347873
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Lentiviral vectors transduce both dividing and non-dividing cells and can support sustained expression of transgenes. These properties make them attractive for the transduction of neurons and other neural cell types in vitro and in vivo. Lentiviral vectors can be targeted to specific cell types by using different promoters in the lentiviral shuttle vector. Even with identical constructs, however, levels of expression can vary significantly in different types of neurons and different culture preparations; expression levels in the same neuronal subtypes can be very different in primary cell culture and in vivo. We systematically assessed the ability of different promoters to direct expression of foreign transgenes in primary murine neocortical neurons, cerebellar granule cells and in undifferentiated and differentiated neuroblastoma cells. In primary cortical neurons, constructs using the ubiquitin C promoter directed the highest level of transgene expression; the phosphoglycerate kinase (PGK) promoter also directed robust transgene expression, while the cytomegalovirus (CMV) and MND (a synthetic promoter that contains the U3 region of a modified MoMuLV LTR with myeloproliferative sarcoma virus enhancer) promoters resulted in the expression of the transgenes in only limited number of neurons. In contrast, in cerebellar granule cells and in differentiated SH-SY5Y neuroblastoma cultures, the CMV promoter directed the most robust transgene expression. There was similar variability in transgene expression directed by these promoters in primary cultures of oligodendrocytes and astrocytes. These findings may prove useful in the design of lentiviral vectors for use in cell culture models of the nervous system.

Citing Articles

Establishment and Characterization of a Stable Producer Cell Line Generation Platform for the Manufacturing of Clinical-Grade Lentiviral Vectors.

Arrasate A, Bravo I, Lopez-Robles C, Arbelaiz-Sarasola A, Ugalde M, Meijueiro M Biomedicines. 2024; 12(10).

PMID: 39457578 PMC: 11504443. DOI: 10.3390/biomedicines12102265.


Fluorescence-Based HTS Assays for Ion Channel Modulation in Drug Discovery Pipelines.

Voldrich J, Matousova M, Smidkova M, Mertlikova-Kaiserova H ChemMedChem. 2024; 19(24):e202400383.

PMID: 39221492 PMC: 11648840. DOI: 10.1002/cmdc.202400383.


Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML.

Lo Presti V, Meringa A, Dunnebach E, van Velzen A, Moreira A, Stam R J Immunother Cancer. 2024; 12(4).

PMID: 38580329 PMC: 11002379. DOI: 10.1136/jitc-2023-008174.


Investigating dynamics of lentiviral vector secretion from HEK293T producer cells using a fractionated perfusion system.

Timmins L, Erickson P, Parekkadan B Biotechnol J. 2023; 19(1):e2300097.

PMID: 37718481 PMC: 11289840. DOI: 10.1002/biot.202300097.


Live-cell imaging of microRNA expression with post-transcriptional feedback control.

Sano M, Morishita K, Oikawa S, Akimoto T, Sumaru K, Kato Y Mol Ther Nucleic Acids. 2021; 26:547-556.

PMID: 34631284 PMC: 8479275. DOI: 10.1016/j.omtn.2021.08.018.


References
1.
Seganti L, Superti F, Girmenia C, Melucci L, Orsi N . Study of receptors for vesicular stomatitis virus in vertebrate and invertebrate cells. Microbiologica. 1986; 9(3):259-67. View

2.
Ambrosini E, Ceccherini-Silberstein F, Erfle V, Aloisi F, Levi G . Gene transfer in astrocytes: comparison between different delivering methods and expression of the HIV-1 protein Nef. J Neurosci Res. 1999; 55(5):569-77. DOI: 10.1002/(SICI)1097-4547(19990301)55:5<569::AID-JNR4>3.0.CO;2-F. View

3.
Davidson B, Breakefield X . Viral vectors for gene delivery to the nervous system. Nat Rev Neurosci. 2003; 4(5):353-64. DOI: 10.1038/nrn1104. View

4.
Dull T, Zufferey R, Kelly M, Mandel R, Nguyen M, Trono D . A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998; 72(11):8463-71. PMC: 110254. DOI: 10.1128/JVI.72.11.8463-8471.1998. View

5.
Lai Z, Brady R . Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector. J Neurosci Res. 2002; 67(3):363-71. DOI: 10.1002/jnr.10137. View